Hyperdynamic left ventricular ejection fraction is associated with higher mortality in COVID-19 patients.

ABSTRACT:

Study objective

To compare the characteristics and outcomes of COVID-19 patients with a hyperdynamic LVEF (HDLVEF) to those with a normal or reduced LVEF.

Design

Retrospective study.

Setting

Rush University Medical Center.

Participants

Of the 1682 adult patients hospitalized with COVID-19, 419 had a transthoracic echocardiogram (TTE) during admission and met study inclusion criteria.

Interventions

Participants were divided into reduced (LVEF < 50%), normal (≥50% and <70%), and hyperdynamic (≥70%) LVEF groups.

Main outcome measures

LVEF was assessed as a predictor of 60-day mortality. Logistic regression was used to adjust for age and BMI.

Results

There was no difference in 60-day mortality between patients in the reduced LVEF and normal LVE

SUBMITTER: Rahman A 

PROVIDER: S-EPMC9013697 | biostudies-literature | 2022 Feb

REPOSITORIES: biostudies-literature